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Abstract 
Background: Previous studies have reported that various non-life-threatening life 
events could cause psychological distress symptoms like posttraumatic stress disorder in 
adults and adolescents. We examined whether patients with treatment-refractory 
depression (TRD) perceive their experiences of life events, of which they think as 
triggering the onset of depression, as more serious psychological distress symptoms 
than remitted or mildly symptomatic patients with major depressive disorder (MDD). 
Methods: This study employed a cross-sectional design. We recruited 78 
outpatients consisting of 31 TRD patients, 31 remitted MDD patients, and 16 mildly 
symptomatic MDD patients. We adopted the Impact of Event Scale-Revised (IES-R) to 
assess the severity of psychological distress symptoms associated with the events that 
patients thought as triggering the onset of depression. We also evaluated clinical 
features and variables including the Hamilton Depression Rating Scale (HDRS). 
Results: The mean [±SD] score of the IES-R in patients with TRD (46.7 [15.1]) 
was significantly higher than in remitted (10.3 [9.9], p < 0.001) or mildly symptomatic 
(31.3 [7.7], p < 0.001) patients with MDD. The HDRS scores showed significant 
correlations with those of the IES-R among all patients (r = 0.811).  
Limitations: This study was not able to exclude the possibility that the severity of 
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psychological distress symptoms associated with onset-related events could influence 
the difficult therapeutic course in patients with TRD due to the cross-sectional design. 
Conclusions: This study demonstrated that patients with TRD perceive their 
onset-related life events as serious psychological distress symptoms. This result 
contributes to understanding the pathophysiology of TRD. 
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1. Introduction 
Major depressive disorder (MDD) is a common mental illness with a high social 
burden. Although pharmacotherapy such as antidepressants plays a pivotal role in the 
treatment of MDD, approximately 20–30% of antidepressant-treated patients with MDD 
are classified as having treatment-refractory depression (TRD) (Fava and Davidson, 
1996; Keller et al., 1992). Previous studies suggest that the concept of TRD is 
advocated as a failure to achieve sufficient remission after at least two adequate 
antidepressant treatment trials during a current depressive episode (Schlaepfer et al., 
2012; Schosser et al., 2012; Souery et al., 2006). Therefore, it is necessary to further 
investigate the clinical features of TRD, to understand the pathophysiology of TRD, and 
to develop better management of patients with TRD. 
Accumulating evidence has reported that physical and psychological stress are 
closely linked with depression (Flynn and Himle 2011). Some reports show that various 
stressful life events (e.g., divorce, unemployment, and public humiliation), which by 
themselves do not lead to fatal outcomes, could trigger depressive disorders (Brown et 
al., 1995; Honkalampi et al., 2005; Hosang et al., 2010; Kendler et al., 1998; Tennant, 
2001). Moreover, it was reported that stressful life events cause symptoms such as 
intrusion, avoidance, and hyperarousal similar to posttraumatic stress disorder (PTSD) 
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in adults and adolescents (Meiser-Stedman et al., 2012; Mol et al., 2005). A recent study 
suggests that childhood trauma (e.g., emotional neglect, psychological abuse) is 
associated with chronic and refractory depression in adults (Hovens et al., 2012). 
However, it is unknown whether patients with TRD perceive psychological distress 
symptoms as being related to adulthood life events, of which they think as triggering the 
onset of depression (here called “onset-related events”). Therefore, we developed the 
hypothesis that patients with TRD perceive symptoms of psychological distress 
including intrusion, avoidance, and hyperarousal as being associated with the life events, 
of which they thought as triggering the onset of depression (here called “onset-related 
psychological distress symptoms”) similar to patients with PTSD.  
The purpose of this study was to determine whether patients with TRD perceive 
their experiences of onset-related events as psychological distress symptoms. We 
conducted a cross-sectional study to assess onset-related psychological distress 
symptoms in patients with TRD, and compare them with remitted MDD patients or 
mildly symptomatic patients with MDD. In addition, we explored the factors of 
onset-related psychological distress symptoms in terms of severity of depression, 
clinical features such as bipolarity, childhood experiences of abuse or stressful events, 
strength of onset-related events, and duration of illness or treatment. 
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2. Methods 
2.1 Study design 
Our study employed a cross-sectional design and was approved by the ethics 
committee of Chiba University Graduate School of Medicine, Sodegaura Satsukidai 
Hospital, and Fujita Hospital. All subjects provided written informed consent for their 
participation in this study after the procedure had been fully explained to them. 
 
2.2 Participants and Procedure 
We surveyed potential candidates from available outpatient charts at Chiba 
University Hospital, Sodegaura Satsukidai Hospital, and Fujita Hospital. This study was 
conducted from November 2012 to November 2013. All subjects were outpatients with 
ages ranging from 20 to 79 years, and were diagnosed with MDD according to the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, text revision 
(DSM-IV-TR) criteria (American Psychiatric Association, 2000) using the Japanese 
version of the Mini International Neuropsychiatric Interview (M.I.N.I.) (Otsubo et al., 
2005; Sheehan et al., 1998). We excluded patients with PTSD, schizophrenia, bipolar 
disorders, comorbid dementia, organic mental disorder, alcohol or drug dependence, 
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mental retardation, or impending suicide attempt. We also excluded patients who were 
hospitalized, under 20 years old, showing poor compliance with medication, and 
uncertain about their life events related to the onset of depression. A total of 247 
outpatients underwent eligibility screening for the study, 158 patients did not meet the 
criteria for eligibility, and 89 patients were eligible to be included in the study. Nine 
patients declined an interview, and 2 patients answered that they experienced no life 
events related to the onset of depression. Finally, 78 patients participated in this study. 
 
2.3 Assessment of depression and Definition of TRD 
We assessed the severity of depression using the Structured Interview Guide for 
the 17-item Hamilton Depression Rating Scale (HDRS-17) (Hamilton, 1967, Williams, 
1988). We applied the criteria for TRD and non-TRD (i.e., remitted or mildly 
symptomatic depression) using the study protocol of Schosser et al. (2012) as a 
reference. In this study, TRD was defined as not reaching an HDRS-17 score of 17 or 
fewer points after two or more antidepressant treatment trials with adequate dosage and 
sufficient duration (i.e., longer than four weeks in the current depressive episode). 
Non-TRD was defined as achieving 17 or fewer point of the HDRS-17 after a single 
antidepressant treatment or after a second course after initial treatment failure. 
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Moreover, within non-TRD, remission of MDD was defined as 7 or fewer points of the 
HDRS-17 score (Frank et al., 1991). The patients who met neither TRD nor remitted 
MDD criteria with an HDRS-17 score between 8 and 17 points, were categorized as 
intermediate MDD. 
 
2.4 Assessments of Clinical Characteristics 
We assessed demographic data such as age, gender, comorbidity, physical diseases, 
family history of psychiatric disorders in first-degree relatives, years of education, 
current employment, present medication, disease and therapy duration, childhood 
stressful life events and abuse before reaching an age of 15 years, and clinical features 
of atypical depression according to the DSM-IV-TR definition. In the current study, 
physical diseases included patients under treatment for hypertension, diabetes, 
hyperlipidemia, lumber disc hernia, and ulcerative colitis. Childhood life events and 
abuse consisted of any of the following: the experience of parental divorce, 
bereavement after the loss of a parent, the experience of strong violence or violent 
language from parent or other people, sexual harassment or abuse, neglect, the 
intervention by the child consultation center, or other stressful experiences. 
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2.5 Measures 
2.5.1 The Impact of Event Scale-Revised 
The Impact of Event Scale-Revised (IES-R) is a self-report measure for assessing 
the severity of symptomatic responses to stressful life events in the past seven days and 
consists of 22 items and three sub-categories, including intrusion (8 items: intrusive 
thoughts, nightmares, intrusive feelings and imagery, re-experiencing), avoidance (8 
items: numbing of responsiveness and avoidance of feelings, situations, and ideas), and 
hyperarousal (6 items: sleep difficulties, anger outbursts, irritability, hyper-vigilance, 
difficulty concentrating, and increased startle) (Weiss, 1997). Each item is rated on a 
5-point scale (0 = not at all, 1 = a little, 2 = moderately, 3 = a lot, 4 = enormously). The 
total sum of points ranges from 0 to 88. The internal consistency and concurrent validity 
of the IES-R was confirmed (Baumert et al., 2004). The Japanese version of the IES-R 
has already been standardized (Asukai et al., 2002). The IES-R was developed and has 
been widely used to evaluate traumatic symptoms in patients with PTSD (Weiss, 1997), 
and covers all aspects of PTSD symptoms such as intrusion, avoidance, and 
hyperarousal. Because we hypothesized that patients with TRD could perceive 
onset-related psychological distress symptoms similar to patients with PTSD, as 
described in the introduction, we adopted the IES-R to evaluate onset-related 
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psychological distress symptoms in this study. We instructed patients to write their 
onset-related event into the blank space of the introduction document of the IES-R, and 
to answer each item of the IES-R regarding their onset-related event. 
 
2.5.2 Life Change Units Value 
To evaluate stress level of life events objectively, we used the social readjustment 
rating scale and scored by the means of Life Change Units Value (LCU) (Holmes and 
Rahe, 1967). The LCU is a rating scale to measure the stress of life events proposed by 
Holmes and Rahe and is based on their multifaceted and extensive investigation. The 
stress of important life events is quantified from 11 to 100 points. For example, 100 
points for the spouse’s death, 73 for divorce, 53 for one’s disease or impairment, 50 for 
marriage, and 20 for change of address. 
2.5.3 Assessment of bipolarity 
We further defined the patients as having bipolarity if they satisfied the criteria of 
either “bipolar spectrum disorder” (Ghaemi et al., 2002) or “bipolarity specifier” (Angst 
et al., 2003a, 2003b). We examined bipolarity in all participants, because several studies 
have demonstrated that there could be a high prevalence of bipolarity in patients with 
TRD (Correa et al., 2010; Dudek et al., 2010; Parker et al., 2005). The concept of 
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bipolar spectrum and bipolarity specifier which suggests that depressive patients with 
subthreshold hypomanic episodes or characteristics of bipolar disorder should be 
considered closer to bipolar depression rather than unipolar depression, has been of 
importance in terms of assessing the clinical condition of mood disorders (Angst and 
Marneros, 2001). 
2.5.4 Assessment of patient’s impression for onset-related events 
We also examined the perceived causal relationship between incidence of 
depression and onset-related event among the patients, using our original questionnaire 
form, which asked each participant to simply answer how much they rated the causal 
relationship between incidence of depression and onset-related event from 1 to 100 
percent. 
 
2.6 Primary Endpoint 
The score of the IES-R for onset-related events for the three groups was set as the 
primary endpoint in this study.  
 
2.7 Statistical Analysis 
We analyzed the data separately for the three groups including TRD, intermediate, 
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and remission group. We performed all analyses using SPSS for Windows, Version 19. 
We employed Chi-square or Fisher’s exact test for categorical variables and Student’s 
t-test or one-way ANOVA for the other variables. We performed one-way ANOVA for 
total and sub-category scores of the IES-R and HDRS-17, followed by Games-Howell 
test for multiple comparisons. We also tested the correlation between HDRS and IES-R 
by means of Pearson’s product moment correlation. The level of significance was set at 
p < 0.05 and the level for power at 0.80. 
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3. Results 
3.1 Characteristics 
 
Table 1  
Characteristics of the patient group with treatment-refractory depression (TRD), 
intermediate group, and remission group. 
 
TRD 
(n = 31) 
Intermediate 
(n = 16) 
Remission 
(n = 31) 
p value 
Age, years (SD) 
[Age range] 
47.3 (12.6) 
[24–64] 
48.6 (12.7) 
[28–67] 
53.5 (13.8) 
[25–77] 
NS 
Gender, male/female 13/18 5/11 12/19 NS 
Education, years (SD) 13.2 (2.5) 13.0 (2.4) 13.9 (1.8) NS 
Current employment (%) 10 (32.3) 9 (56.3) 15 (48.4) NS 
Psychiatric comorbidity (%) 8 (25.8) 4 (25.0) 4 (12.9) NS 
Physical disease (%) 19 (61.3) 8 (50.0) 20 (64.5) NS 
Family psychiatric history (%) 13 (41.9) 7 (43.8) 8 (25.8) NS 
Childhood life events and abuse 
(%) 
10 (32.3) 7 (43.8) 7 (22.6) NS 
LCU of life events, points (SD) 48.1 (30.0) 50.4 (22.8) 44.2 (24.7) NS 
HDRS-17 items, points (SD) 23.2 (3.4) 11.5 (3.0) 3.6 (2.0) < 0.001* 
Atypical depression (%) 5 (16.1) 1 (6.3) 1 (3.2) NS 
Disease duration, months 87.5 (52.6) 85.4 (70.6) 94.3 (69.9) NS 
Therapy duration, months 70.8 (41.9) 73.9 (61.2) 77.1 (71.7) NS 
Note: Variables represent mean (standard deviation: SD) 
Abbreviations: LCU, Life Change Units Value; HDRS, Hamilton Depression Rating 
Scale; NS, not significant.  
*The data for three groups were analyzed with one-way ANOVA, followed by 
Games-Howell test for multiple comparisons. 
 
The characteristics of participants included in the analysis are presented in Table 1. 
The 78 patients with MDD consisted of three groups: the TRD group (n = 31), 
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remission group (n = 31), and intermediate group (n = 16). There were no significant 
differences in age, gender, and years of education between the three groups. 
Furthermore, there were no significant differences in the proportion of current 
employment, physical diseases, psychiatric comorbidity, and first-degree relatives with 
psychiatric disorders between the three groups. As for the breakdown of psychiatric 
comorbidities, there were patients with dysthymic disorder (n = 3), social anxiety 
disorder (n = 3), panic disorder (n = 1), generalized anxiety disorder (n = 1), pain 
disorder (n = 1), and bulimia nervosa (n = 1) in the TRD group, and two patients of this 
group suffered from double psychiatric comorbidities. Psychiatric comorbidities in the 
intermediate group consisted of social anxiety disorder (n = 1), panic disorder (n = 2), 
generalized anxiety disorder (n = 1), and obsessive-compulsive disorder (n = 1), and one 
patient of this group suffered from double comorbidity. In the remission group, 
psychiatric comorbidities included social anxiety disorder (n = 1), panic disorder (n = 1), 
generalized anxiety disorder (n = 1), and obsessive-compulsive disorder (n = 2), and one 
patient suffered from double comorbidity.  
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Table 2 
The breakdown of onset-related life events and the patient’s impression about 
causal relationship between incidence of depression and onset-related event. 
 
TRD 
(n = 31) 
Intermediate 
(n = 16) 
Remission 
(n = 31) 
Job-related events 15 4 20 
Family-related events 14 6 6 
Health-related events 5 2 7 
Money-related events 3 1 1 
Other events 1 3 0 
Overlapping events 7 0 1 
Patients’ impression of causal relationship 
between their events and depression* 
n n n 
100 % 10 3 9 
81–99 % 12 7 14 
61–80 % 6 2 4 
41–60 % 2 3 4 
21–40 % 1 1 0 
1–20 % 0 0 0 
Abbreviation: TRD, treatment-refractory depression 
*Degree in percentage of patients’ impression of causal relationship between their 
stressful life events around the time of onset and depression. 
 
Table 2 shows the breakdown of onset-related life events among all participants. 
Many patients thought there was greater than 80% in percentage of patients’ impression 
of causal relationship between their stressful life events around the time of onset and 
depression (70.9% in TRD, 62.5% in intermediate, and 74.2% in remission group).  
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Table 3 
Medication profiles of the three patient groups. 
Class of medication TRD  
(n = 31) 
Intermediate 
(n = 16) 
Remission 
(n = 31) 
 n n n 
Antidepressants (AD)    
 SSRI 17 7 16 
 SNRI 8 5 4 
 NaSSA 4 3 5 
 Trazodone 2 2 2 
 Other 4 3 6 
 Total  35 20 33 
Benzodiazepine (BZ) 22 9 19 
Mood stabilizers (MS)    
 Lithium 2 0 1 
 Valproic acid 2 1 0 
 Lamotrigine 5 0 0 
 Total (MS) 9 1 1 
Antipsychotics (AP)    
 Olanzapine 1 2 0 
 Quetiapine 3 0 0 
 Aripiprazole 1 0 1 
 Other 1 0 0 
 Total (AP) 6 2 1 
Medication combination    
 Single drug (AD) 1 4 9 
Two AD 1 1 0 
AD+BZ 12 7 16 
AD+MS 3 0 1 
AD+AP 1 0 1 
Three or more classes  8 2 0 
Other 5 2 4 
Abbreviation: TRD, treatment-refractory depression 
 
Table 3 shows the medication profiles for all participants. The combination of 
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antidepressant and benzodiazepine was the predominant profile for each group (38.7% 
in TRD, 43.8% in intermediate, and 51.6% in remission group). The proportion of 
patients treated with a single antidepressant was highest in the remission group (29.0%). 
On the other hand, almost all patients with TRD had been treated with multiple-drug 
combination therapy. 
 
3.2 The scores of the IES-R for onset-related events 
 
Figure 1. IES-R scores (total and sub-categories: intrusion, avoidance, and 
hyperarousal) for treatment-refractory depression (TRD), remission, and intermediate 
group. 
＊Comparison between TRD and remission group (p < 0.001); †comparison between 
TRD and intermediate group (p < 0.001); §comparison between intermediate and 
remission group (p < 0.001). 
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Figure 1 shows the IES-R for onset-related events for all groups. The total score 
of the IES-R showed a significant difference between the three groups (F (2) = 72.81, p 
< 0.001). Post-hoc analysis showed significant differences between each group; the 
IES-R total score was significantly higher in the TRD group (mean = 46.7, standard 
deviation (SD) = 15.1) than intermediate (mean = 31.3, SD = 7.7; t (45) = 4.63, 95%CI 
7.34–23.45, p < 0.001), and remission MDD group (mean = 10.3, SD = 9.9; t (60) = 
11.25, 95%CI 28.61–44.23, p < 0.001). The total score of the IES-R was also 
significantly higher in the intermediate than remission group (t (45) = 7.40, 95%CI 
14.62–27.42, p < 0.001). 
As shown in Figure 1, for each sub-category of the IES-R, there were significant 
differences between the three groups: intrusion (F (2) = 42.65, p < 0.001), avoidance (F 
(2) = 28.92, p < 0.001), and hyperarousal (F (2) = 81.48, p < 0.001). Each sub-category 
score of the TRD group was significantly higher compared to the intermediate and 
remission group. For intrusion, the mean score of the TRD group was 16.4 (SD = 7.6), 
while it was lower for the intermediate (mean = 11.6, SD = 4.8) and remission group 
(mean = 3.2, SD = 3.5). For avoidance, the mean score of the TRD group was 16.0 (SD 
= 5.6), while it was lower for the intermediate (mean = 12.4, SD = 6.5) and remission 
group (mean = 5.2, SD = 5.3). For hyperarousal, the mean score of the TRD group was 
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14.3 (SD = 5.0), while it was lower for the intermediate (mean = 7.3, SD = 3.1) and 
remission group (mean = 2.0, SD = 2.4). 
 
3.3 The relationship between the IES-R and the HDRS 
There was a significant positive correlation between the score of the IES-R for 
onset-related events and the HDRS for all three groups combined (r = 0.82, p < 0.001), 
although there were no correlations between the two measures within each group. There 
were no significant correlations between the IES-R score and the duration of disease, 
nor were there significant correlations between the IES-R score and duration of 
treatment. Furthermore, there was no correlation between the IES-R score and the LCU. 
There were no significant differences between the scores of the IES-R for patients with 
or without childhood life events or abuse, neither in all patients nor in the patients with 
TRD. 
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3.4 Relationship between TRD and bipolarity 
Table 4 
IES-R and HDRS scores in MDD patients with or without bipolarity. 
All patients 
With 
bipolarity 
Without 
bipolarity 
T ratio1 
[d.f.] 
95%CI1 
p value1 
78 19 59    
IES-R 41.9 (18.3) 24.9 (19.1) 3.41 [76] 7.09–26.94 0.001 
HDRS 17.4 (9.1) 11.6 (9.0) 2.44 [76] 1.07–10.51 0.017 
Note: Variables represent mean (standard deviation: SD) 
Abbreviations: IES-R, Impact of Event Scale-Revised; HDRS, Hamilton Depression 
Rating Scale; MDD, major depressive disorder 
1Statistical analysis was performed by Student’s t-test. 
 
The number of patients with bipolarity were calculated for the TRD (n = 10), 
intermediate (n = 6), and remission group (n = 3). The TRD group had a significantly 
higher ratio of patients with bipolarity than the remission group, as confirmed by a 
Chi-square test (p = 0.028). In more detail, the number of patients meeting the criteria 
of bipolar spectrum disorder were counted for the TRD (n = 2), intermediate (n = 3), 
and remission group (n = 0). The numbers of patients meeting the criteria of bipolarity 
specifier were assessed for the TRD (n = 9), intermediate (n = 5), and remission group 
(n = 3). One patient in the TRD and two patients in the intermediate group met the 
criteria of both bipolar spectrum disorder and bipolarity specifier. Table 4 shows the 
relationship between patients with or without bipolarity and two clinical variables such 
as the IES-R for onset-related events and the HDRS for all participants. The IES-R and 
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HDRS scores were significantly higher in patients with bipolarity than in those without 
bipolarity. 
 
4. Discussion 
In this study, we made three important clinical observations. First, the main 
finding of our study was that patients with TRD perceive their onset-related events as 
more serious psychological distress symptoms than patients with remitted MDD or 
MDD patients with mild residual depressive symptoms. Second, our results demonstrate 
that the severity of depressive symptoms shows a significant positive correlation with 
the severity of onset-related psychological distress symptoms in patients with MDD. 
Third, our study further shows that the clinical feature of bipolarity might be associated 
with severe depressive symptoms and onset-related psychological distress symptoms in 
patients with MDD. 
The first main finding of our study was that patients with TRD think of their 
onset-related events as more serious psychological distress symptoms than those with 
remitted MDD or MDD patients with mild residual depressive symptoms. To our 
knowledge, this is the first study to demonstrate that patients with TRD perceive their 
experiences of onset-related events as serious psychological distress symptoms such as 
intrusion, avoidance, and hyperarousal. It has been reported that clinical factors 
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including comorbid psychiatric disorders such as panic disorder and anxiety disorders, 
current suicidal risk, lack of full remission after a previous episode, age at onset 
younger than eighteen years, and bipolarity are related to TRD (Dudek et al., 2010; 
Souery et al., 2007). Regarding additional clinical factors, it is suggested that 
neuroticism and excessive pessimistic and negative thinking are involved in treatment 
resistant depression (Thase et al., 2001). Our findings may present not only a new 
perspective on clinical symptoms of TRD, but also suggest additional clinical factors 
associated with TRD.  
Our results demonstrate that the severity of depressive symptoms is positively 
correlated with the severity of onset-related psychological distress symptoms in patients 
with MDD. This result should be interpreted in two ways: (1) Onset-related 
psychological distress symptoms directly affect depressive symptoms and may 
contribute to a worse prognosis for patients with MDD, although prospective cohort 
studies are needed to establish this concept. (2) The severity of the depressive state may 
affect cognitive distortions in depressed patients, and consequently elicit onset-related 
psychological distress symptoms. The possibility of a cognitive negative bias induced 
by the depressive state should be considered further (Beck, 2008). Patients with MDD 
tend to have pessimistic thoughts and recognize their future as hopeless when suffering 
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from severe depression (Abramson et al., 1978). Consequently, it has been implied that 
cognitive distortions occur in depressed patients (Beck, 2008). From a neuroscience 
perspective, it was suggested that the human condition of depression could damage glial 
and neuronal cells in the hippocampus and reduce hippocampal volume (Campbell et al., 
2004; Videbech and Ravnkilde, 2004). It was further reported that the morphologic 
change of the hippocampus could induce memory impairments in patients with 
depression (Sheline et al., 1999). Moreover, it was reported that the clinical condition of 
depression in particular induces impairment in declarative memory (Burt et al., 1995). It 
may be possible that patients with depression recall their past life events such as 
onset-related events with a bias due to distorted cognition. As a consequence of 
distorted cognition and memory impairment, patients with TRD may develop a more 
negative impression of their life events compared to mild or remitted MDD patients.  
The present results showed that onset-related psychological distress symptoms are 
more severe in MDD patients with bipolarity than in those without bipolarity. In 
addition, our results suggest that TRD patients with bipolarity tend to experience 
severer onset-related psychological distress symptoms than TRD patients without 
bipolarity. It has been suggested that patients with clinical features of bipolarity share 
clinical similarities to patients with bipolar disorders rather than with unipolar 
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depression on the basis of the concept of bipolar spectrum (Akiskal, 1995; Akiskal et al., 
2006). Several studies suggest that patients with bipolar disorders have a higher 
prevalence of PTSD than those with MDD (Otto et al., 2004; Pollack et al., 2006). A 
high prevalence of traumatic experiences in patients with severe mental disorder such as 
bipolar disorder has been reported (Mueser et al., 1998). Moreover, the relationship 
between bipolar disorder and PTSD has received further support by findings of 
molecular biology, which implicates that low secretion of brain-derived neurotrophic 
factor (BDNF) in the human brain may be a risk factor for the onset of PTSD (Rakofsky 
et al., 2012), and the production of BDNF may also be reduced in patients with bipolar 
disorder (Rakofsky et al., 2012). The relationship between the clinical factor of 
bipolarity and onset-related psychological distress symptoms in depressed patients 
observed in the current study might contribute to adding a new perspective to the 
concept of mood disorders. 
Our main finding that patients with TRD perceive their onset-related events as 
serious psychological distress symptoms such as intrusion, avoidance, and hyperarousal 
could not only be useful to improve understanding of clinical features of TRD, but also 
presents the potential for new perspectives in the treatment of TRD. Regarding the role 
of psychotherapy in the management of TRD, cognitive-behavioral therapy and 
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interpersonal psychotherapy have been recommended as evidence-based treatments in 
combination with antidepressant medication (Flynn and Himle, 2011; Thase, 2013). On 
the basis of our finding, it may be effective to incorporate psychological intervention 
targeting psychological distress symptoms associated with onset-related events for 
patients with TRD. For example, psychotherapy techniques of prolonged exposure and 
cognitive restructuring may be effective in the treatment of TRD as well as PTSD 
(Marks et al., 1998). It was reported that prolonged exposure therapy improved 
symptoms of depression in patients with PTSD (Eftekhari et al., 2013). Using imaginal 
exposure for traumatic life-event memories or reappraising TRD patients’ beliefs about 
their life events, which they thought as triggering the onset of depression, may be useful 
for the treatment of TRD.  
In terms of pharmacotherapy for psychological distress, several case series 
reported that treatment with ifenprodil was effective for patients with PTSD, especially 
for treating flashbacks (Kishimoto et al., 2012; Sasaki et al., 2013). Ifenprodil is a 
neuroprotective drug that acts as an antagonist of the N-methyl-D-aspartate (NMDA) 
receptor, by binding to the GluN2B subunit (Williams, 2001). Ifenprodil also binds to 
the endoplasmic reticulum protein sigma-1 receptors (Hashimoto and London, 1993, 
1995). Sigma-1 receptors play a role in the pathophysiology of neuropsychiatric 
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diseases (Hashimoto and Ishiwata, 2006). Future studies examining treatment of TRD 
patients by psychotherapy and pharmacotherapy, such as ifenprodil treatment, may be 
needed. 
 
4.1 Limitations  
Three issues need to be discussed for the limitations. First, this study was not able 
to exclude the possibility that the severity of onset-related psychological distress 
symptoms could cause the difficult therapeutic course in patients with TRD, because a 
cross-sectional design was implemented as the method of this study. To resolve this 
problem, prospective cohort studies are needed in the future. For the same reason, this 
study was not able to eliminate potential confounding factors, even if certain patient 
characteristics did not differ significantly between the three groups. Second, the 
limitation of the assessment method for onset-related psychological distress symptoms 
in patients with MDD should be acknowledged. Although the contents of the IES-R 
cover all aspects of psychological traumatic symptoms, the IES-R has been originally 
developed and used for a rating scale of PTSD severity. To establish validity and 
reliability of the assessment of onset-related psychological distress symptoms, further 
studies are needed to include a multilateral approach to assess symptoms of 
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psychological distress in patients with MDD. Third, the recall bias might present an 
additional problem with this study, because the participants were requested to recall past 
life events. 
 
5. Conclusion 
This study confirmed that patients with TRD perceive their experiences of 
onset-related events as serious psychological distress symptoms. Future studies should 
be conducted to confirm distress symptoms in MDD or depressed patients with a wide 
range of clinical features, and to investigate the pathophysiology of psychological 
distress in patients with TRD through neuropsychological examinations and brain 
imaging techniques. 
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